We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
-9.79%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$15.2B
AUM Growth
+$1.6B
(+12%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
21.34%
Top 10 Holdings %
Top 10 Hldgs %
29.96%
Holding
340
New
2
Increased
168
Reduced
112
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$144M |
| 2 |
Merck
MRK
|
+$129M |
| 3 |
Truist Financial
TFC
|
+$127M |
| 4 |
Fidelity National Information Services
FIS
|
+$118M |
| 5 |
Procter & Gamble
PG
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$72.4M |
| 2 |
Verisk Analytics
VRSK
|
+$14.3M |
| 3 |
Baxter International
BAX
|
+$13.4M |
| 4 |
Valero Energy
VLO
|
+$7.77M |
| 5 |
MANT
Mantech International Corp
MANT
|
+$3.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.07% |
| 2 | Healthcare | 15.38% |
| 3 | Financials | 13.89% |
| 4 | Consumer Staples | 11.75% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Edwards Lifesciences
EW
$51.7B
| – | – |
-2,314
| Closed | -$272K |
|
327
Fortune Brands Innovations
FBIN
$6.06B
| – | – |
-3,285
| Closed | -$209K |
|
328
Goldman Sachs
GS
$303B
| – | – |
-667
| Closed | -$220K |
|
329
John B. Sanfilippo & Son
JBSS
$972M
| – | – |
-20,556
| Closed | -$1.72M |
|
|
JNPR
330
DELISTED
Juniper Networks
JNPR
| – | – |
-46,604
| Closed | -$1.73M |
|
331
Rockwell Automation
ROK
$49B
| – | – |
-932
| Closed | -$261K |
|
332
TD Synnex
SNX
$20.2B
| – | – |
-2,217
| Closed | -$229K |
|
333
T. Rowe Price
TROW
$24.3B
| – | – |
-1,400
| Closed | -$212K |
|
334
Tractor Supply
TSCO
$18B
| – | – |
-4,400
| Closed | -$205K |
|
|
CCMP
335
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| – | – |
-1,148
| Closed | -$213K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q2 2022 Portfolio in Review
As of Q2 2022, Bahl & Gaynor held 340 positions worth $15.2B, up 12% from $13.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bahl & Gaynor deployed $3.24B of net new capital in Q2 2022, opening 2 new positions and adding to 168 existing holdings. Its largest new stake was Victory Capital Holdings: 323,736 shares worth $7.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $72.4M trimmed.
- Bahl & Gaynor's largest Q2 2022 buy was Victory Capital Holdings: 323,736 shares worth $7.8M.
- Bahl & Gaynor added most to PNC Financial Services in Q2 2022, an estimated $144M increase.
- Bahl & Gaynor's biggest Q2 2022 reduction was JPMorgan Chase, cutting an estimated $72.4M.
- Bahl & Gaynor fully exited Juniper Networks in Q2 2022, selling an estimated $1.73M.
- Bahl & Gaynor's ten largest holdings make up 30% of its $15.2B portfolio in Q2 2022.
- Bahl & Gaynor opened 2 new positions and closed 15 in Q2 2022.
- Bahl & Gaynor's portfolio value rose 12% quarter-over-quarter to $15.2B.
Based on Bahl & Gaynor's 13F filing for Q2 2022, filed 8 Aug 2022.